XLR Medical Corp. is a blank check company, which engages in pursuing potential new business opportunity by way of a merger and acquisition with an unidentified company, an acquisition of assets, and other form of business combination. The company was founded on February 2, 2001 and is headquartered in Long Beach, NY.
Company profile
Ticker
BLMS
Exchange
CEO
Bryan Glass
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
RELAY MINES LTD, XLR MEDICAL CORP.
SEC CIK
Corporate docs
IRS number
880488851
BLMS stock data
Latest filings (excl ownership)
15-12G
Securities registration termination
28 Mar 24
8-K
Changes in Control of Registrant
28 Mar 24
8-K
Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
7 Mar 24
8-K
Changes in Control of Registrant
20 Nov 23
10-Q
2023 Q3
Quarterly report
20 Nov 23
NT 10-Q
Notice of late quarterly filing
15 Nov 23
10-Q
2023 Q2
Quarterly report
21 Aug 23
NT 10-Q
Notice of late quarterly filing
14 Aug 23
424B3
Prospectus supplement
29 Jun 23
EFFECT
Notice of effectiveness
29 Jun 23
Latest ownership filings
3
Douglas S Rohrer
2 Dec 22
3
Initial statement of insider ownership
29 Mar 22
3
bibi daprile
17 Sep 21
3
aline hayuta elkayam
17 Sep 21
4
MICHAEL HILL
11 Aug 21
3
Initial statement of insider ownership
11 Aug 21
3
BARRETT EVANS
11 Aug 21
3
Initial statement of insider ownership
11 Aug 21
3
MICHAEL HILL
7 Dec 20
SC 13D
XLR Medical Corp.
5 Aug 19
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Jan 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | ||||||
Cash burn (monthly) | (no burn) | 696.67 | 8.68 mm | 3.30 mm | 389.93 k | 592.82 k |
Cash used (since last report) | n/a | 4.79 k | 59.64 mm | 22.68 mm | 2.68 mm | 4.07 mm |
Cash remaining | n/a | -4.79 k | -59.64 mm | -22.68 mm | -2.68 mm | -4.07 mm |
Runway (months of cash) | n/a | -6.9 | -6.9 | -6.9 | -6.9 | -6.9 |